BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27000403)

  • 1. The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion.
    Masroori N; Merindol N; Berthoux L
    Retrovirology; 2016 Mar; 13():19. PubMed ID: 27000403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines.
    Masroori N; Cherry P; Merindol N; Li JX; Dufour C; Poulain L; Plourde MB; Berthoux L
    mSphere; 2017; 2(3):. PubMed ID: 28656178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
    Chen Y; Wright J; Meng X; Leppard KN
    Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML positively regulates interferon gamma signaling.
    El Bougrini J; Dianoux L; Chelbi-Alix MK
    Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx.
    Dutrieux J; Maarifi G; Portilho DM; Arhel NJ; Chelbi-Alix MK; Nisole S
    PLoS Pathog; 2015 Nov; 11(11):e1005280. PubMed ID: 26566030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM19/PML Restricts HIV Infection in a Cell Type-Dependent Manner.
    Kahle T; Volkmann B; Eissmann K; Herrmann A; Schmitt S; Wittmann S; Merkel L; Reuter N; Stamminger T; Gramberg T
    Viruses; 2015 Dec; 8(1):. PubMed ID: 26703718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of PMLIV in both intrinsic and innate immunity.
    El Asmi F; Maroui MA; Dutrieux J; Blondel D; Nisole S; Chelbi-Alix MK
    PLoS Pathog; 2014 Feb; 10(2):e1003975. PubMed ID: 24586174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implication of PML nuclear bodies in intrinsic and innate immunity].
    Maroui MA; El Asmi F; Dutrieux J; Chelbi-Alix MK; Nisole S
    Med Sci (Paris); 2014; 30(8-9):765-71. PubMed ID: 25174753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus.
    Kim YE; Ahn JH
    PLoS Pathog; 2015 Mar; 11(3):e1004785. PubMed ID: 25812002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication.
    Mitchell AM; Hirsch ML; Li C; Samulski RJ
    J Virol; 2014 Jan; 88(2):925-36. PubMed ID: 24198403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sp100 isoform-specific regulation of human adenovirus 5 gene expression.
    Berscheminski J; Wimmer P; Brun J; Ip WH; Groitl P; Horlacher T; Jaffray E; Hay RT; Dobner T; Schreiner S
    J Virol; 2014 Jun; 88(11):6076-92. PubMed ID: 24623443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
    Vicenzi E; Poli G
    Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a different susceptibility of primate lentiviruses to type I interferons.
    Cordeil S; Nguyen XN; Berger G; Durand S; Ainouze M; Cimarelli A
    J Virol; 2013 Mar; 87(5):2587-96. PubMed ID: 23255800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.
    Regad T; Saib A; Lallemand-Breitenbach V; Pandolfi PP; de Thé H; Chelbi-Alix MK
    EMBO J; 2001 Jul; 20(13):3495-505. PubMed ID: 11432836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
    Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
    Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.
    Sobol PT; Hummel JL; Rodrigues RM; Mossman KL
    Gene Ther; 2009 Sep; 16(9):1077-87. PubMed ID: 19474810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
    Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
    Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1.
    Forlani G; Tosi G; Turrini F; Poli G; Vicenzi E; Accolla RS
    Front Immunol; 2017; 8():564. PubMed ID: 28555140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of TRIM19 by arterivirus nonstructural protein 1 promotes viral replication.
    Su CM; Hung YF; Tang J; Han M; Everett R; Yoo D
    Virus Res; 2024 Feb; 340():199302. PubMed ID: 38104946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.